Sales of Biden's Murderous Covid Treatment Remdesivir Soar to $5.6 Billion
Renee Nal | February 4, 2022Remdesivir, sold as “Veklury” saw sales increase 98% from 2020 to 2021, netting $5.6 billion for Gilead Sciences. Remdesivir is ineffective against the coronavirus but is also dangerous, as reported at RAIR Foundation USA.
Despite the dangers, on January 21, 2022, the Food and Drug Administration (FDA) expanded the use of remdesivir to include “certain non-hospitalized adults and pediatric patients for the treatment of mild-to-moderate COVID-19 disease.”
At $3,120 per patient, remdesivir is more expensive than known effective treatments for the coronavirus. Hospitals are incentivized to use the failed treatment remdesivir on coronavirus patients.
Notably, highly effective monoclonal antibodies have been seized by the Biden team. . . .
https://rairfoundation.com/sales-of-bidens-murderous-covid-treatment-remdesivir-soar-to-5-6-billion/
Institutionalized corruption. Except people are dying over this.